Control of cell division by an Acinetobacter baumannii protein with a novel nucleotidyl-cyclase-like fold

This study elucidates how the essential *Acinetobacter baumannii* protein AdvA, which features a novel nucleotidyl-cyclase-like fold lacking canonical catalytic sites, orchestrates cell division by recruiting and activating divisome components, thereby offering a potential new target for antimicrobial strategies against this multidrug-resistant pathogen.

The Gist

Imagine a bacterial cell as a tiny, bustling factory that needs to split in half to reproduce. In most bacteria (like the common E. coli), this factory has a well-known "foreman" named FtsEX who stands at the center, checks the blueprints, and gives the green light to start the division process.

But the super-bug Acinetobacter baumannii is different. It's a multidrug-resistant nightmare that causes serious infections in hospitals. Scientists discovered that this bug doesn't have the FtsEX foreman. Instead, it relies on a unique, mysterious protein called AdvA to run the show.

This paper is like a detective story where scientists finally figured out how AdvA works, what it looks like, and why it's so critical for the bacteria's survival. Here is the breakdown in simple terms:

1. The Mystery of the "Broken" Protein

Scientists knew AdvA was essential. If they broke the gene, the bacteria couldn't divide and would grow into long, useless strings (like a factory that keeps adding rooms but never opens a new door).

However, there was a weird clue: When they tried to break the gene with a "molecular dart" (a transposon), the darts only stuck in the middle of the protein.

• The Analogy: Imagine a long rope. If you cut the rope at the very end, the factory keeps running. If you cut it in the middle, the factory stops. But if you cut it near the very end, the factory also stops!
• The Discovery: The scientists realized the protein has two main parts:
  • The Anchor (N-terminus): This part sticks into the cell wall and grabs onto the construction crew. It's essential.
  • The Control Knob (C-terminus): This part floats inside the cell. Surprisingly, if you just cut off the very end of this knob, the whole machine breaks.

2. The "Swiss Army Knife" Structure

The scientists took a 3D picture (using X-ray crystallography) of the Control Knob.

• The Shape: It looked like a famous machine part used by other bacteria called a "Cyclase" (which usually makes chemical signals).
• The Twist: But this wasn't a normal machine part. It was missing the gears that make it work as a chemical maker. It was a fake-out.
• The Secret Weapon: The scientists found a tiny, extra "tail" (a helix) at the very end of this fake machine. This tail is like a safety latch.
  • If the latch is there, the protein works.
  • If you cut off the latch (which explains why darts in the middle of the gene kill the bacteria), the protein falls apart and the factory shuts down.

3. How AdvA Runs the Factory

Since AdvA doesn't make chemical signals, what does it do? It acts as a Master Connector.

• The Job: AdvA grabs onto the early construction crew (like a protein named ZipA) and holds them in place.
• The Chain Reaction: Once AdvA is locked in, it signals the rest of the crew (the "divisome") to assemble. It's like a conductor raising a baton; once the conductor is in place, the orchestra starts playing.
• The Proof: When the scientists removed AdvA, the construction crew scattered. The Z-rings (the blueprints for division) formed, but the workers never showed up to build the wall.

4. The "Backdoor" Escape

The researchers found something fascinating: If they mutated two other proteins in the factory (FtsB and FtsW), the bacteria could survive without AdvA.

• The Analogy: It's like a security system (AdvA) that usually guards the door. But if you jam the lock on the door itself (mutating FtsB/FtsW), the security guard becomes unnecessary because the door is already stuck open.
• The Lesson: This tells us AdvA's main job is to activate the machinery that builds the cell wall. Without AdvA, the machinery is asleep.

5. Why This Matters for Medicine

• The Weakness: Because Acinetobacter uses this unique "fake machine" (AdvA) instead of the standard "foreman" (FtsEX) that other bacteria use, we can't use the same drugs to kill it.
• The Opportunity: This protein is a brand new target. If we can design a drug that jams that "safety latch" (the extra tail) or breaks the connection between AdvA and the construction crew, we could stop this super-bug from dividing.
• The Bonus: The study also found that a similar protein exists in Pseudomonas aeruginosa, another dangerous hospital bug. This suggests a whole new class of bacterial control proteins that we can attack.

Summary

Think of Acinetobacter baumannii as a car that doesn't have a standard ignition key. Instead, it has a unique, custom-made AdvA switch. This switch looks like a key but doesn't turn the engine; instead, it acts as a magnetic connector that snaps the engine parts together. The scientists found that this switch has a tiny, critical safety pin at the end. If you pull that pin, the switch falls apart, the engine parts scatter, and the car (the bacteria) can't move.

By understanding exactly how this unique switch works, scientists have found a new way to potentially stop these super-bugs from multiplying, offering hope for new antibiotics against infections that are currently hard to treat.

Technical Summary

1. Problem Statement

Acinetobacter baumannii is a multidrug-resistant (MDR) Gram-negative pathogen causing severe nosocomial infections. Unlike model organisms like Escherichia coli, A. baumannii lacks the conserved FtsEX complex, a critical regulator of cell division in most bacteria. Instead, it relies on a suite of atypical, uncharacterized proteins. One such protein, AdvA (also known as Aeg1), was previously identified as essential for cell division and fluoroquinolone resistance. However, its molecular mechanism, structural basis, and the reason for the specific distribution of viable transposon insertions within its gene (lethal in the N-terminal region and C-terminal region, but tolerated in a central linker) remained unknown.

2. Methodology

The authors employed a multidisciplinary approach combining genetics, structural biology, and microbiology:

• Genetic Manipulation: Used a dual-promoter gene-swapping system (P(IPTG)-advA vs. P(Ara)-advA-msGFP2) to replace the endogenous advA with various truncation and point-mutant alleles. This allowed for the assessment of viability, growth defects, and antibiotic susceptibility.
• Microscopy: Utilized fluorescence microscopy to track AdvA localization (GFP fusions) and divisome assembly (ZapA-mCherry for Z-rings and GFP fusions for other divisome proteins like ZipA, FtsK, FtsB, FtsW, FtsN) under conditions of AdvA depletion.
• Protein-Protein Interaction: Employed the Bacterial Adenylate Cyclase Two-Hybrid (BACTH) system to map interactions between AdvA domains and core divisome proteins.
• Suppressor Analysis: Isolated spontaneous mutants that bypassed AdvA essentiality and mapped them via whole-genome sequencing. Validated suppressors using CRISPRi-mediated depletion.
• Structural Biology: Purified the cytoplasmic domain of AdvA (residues 158–435) and solved its crystal structure using X-ray crystallography (1.65 Å resolution). Structural comparisons were made using DALI and AlphaFold.
• Enzymatic Assays: Tested for nucleotidyl cyclase (AC/GC) activity using in vivo reporter systems (cAMP/cGMP detection) and in vitro assays for pyrophosphate and phosphate release.

3. Key Contributions and Results

A. Functional Domains and Transposon Effects

• N-terminal Essentiality: The N-terminal transmembrane (TM) and periplasmic domains are essential for viability, midcell localization, and divisome recruitment. Truncations lacking these domains fail to support growth.
• C-terminal Regulation: The C-terminal cytoplasmic domain is not strictly essential for viability (a truncation at residue 230 supports growth but causes filamentation and fluoroquinolone hypersensitivity). However, the very C-terminal end is critical; truncations removing the final ~30 residues (specifically the $\alpha$6 helix) are lethal.
• Explanation of Transposon Bias: The study explains the Tn-seq data: insertions in the N-terminus are lethal due to loss of essential TM/periplasmic functions. Insertions in the C-terminus (after the linker) are lethal because they remove the critical $\alpha$6 helix required for function. Insertions in the central linker (residues ~208–244) are tolerated because they preserve the essential N-terminal domains while removing the inhibitory or regulatory C-terminal tail.

B. Role in Divisome Assembly

• Recruitment: AdvA is required for the recruitment of both early (ZipA, FtsA) and late (FtsB, FtsW, FtsN) divisome proteins to the Z-ring. Depletion of AdvA leads to a failure in divisome assembly, resulting in cell filamentation.
• Interaction Network:
  • The N-terminal TM/periplasmic domain interacts broadly with at least 8 core divisome proteins (FtsA, ZipA, FtsL, FtsN, FtsB, FtsW, FtsI, FtsQ).
  • The C-terminal cytoplasmic domain specifically interacts with ZipA.
• Bypass Suppressors: Mutations in FtsB (D68G) and FtsW (A213V) were identified that bypass the essentiality of AdvA. These mutations likely constitutively activate septal peptidoglycan synthesis, suggesting AdvA normally acts as a checkpoint to activate these enzymes.

C. Structural Discovery: A Novel Cyclase-Like Fold

• Crystal Structure: The cytoplasmic domain (residues 226–420) adopts a fold resembling Type III nucleotidyl cyclases (specifically the Cyclase Homology Domain or CHD of Adenylyl/Guanylyl Cyclases).
• Key Structural Deviations:
  • No Catalytic Activity: Unlike canonical cyclases, AdvA lacks the dimerization "arm" (antiparallel $\beta$-strands) and most catalytic residues. Enzymatic assays confirmed no AC, GC, or NTPase activity.
  • Unique Features: The structure contains an extra C-terminal $\alpha$-helix ($\alpha$6) and a positively charged tip (involving residues K239 and R324).
  • Function of $\alpha$6: The $\alpha$6 helix is essential for AdvA homodimerization, interaction with divisome proteins, and midcell localization. Its removal renders the protein non-functional.
  • Function of the Positively Charged Tip: Mutating the conserved residue R324 to Alanine causes hypersusceptibility to ciprofloxacin and mild division defects, suggesting this surface is critical for specific interactions (likely with ZipA) and antibiotic resistance.

D. Evolutionary Context

• AdvA homologs are restricted to the Moraxellaceae family (which lacks FtsEX).
• A distant structural homolog, PA4961, was identified in Pseudomonas aeruginosa. Despite low sequence identity, PA4961 shares the unique CHD-like fold, the extra C-terminal helix, and the lack of catalytic residues, suggesting a convergent evolutionary solution for cell cycle control in pathogens that may or may not possess FtsEX.

4. Significance

• Mechanistic Insight: The paper defines a novel mechanism for cell division control in A. baumannii that replaces the missing FtsEX complex. AdvA acts as a central hub, bridging early Z-ring components (via ZipA) with late divisome components to activate septal synthesis.
• Structural Novelty: It identifies a new class of regulatory proteins that utilize a modified nucleotidyl cyclase fold for structural scaffolding and protein-protein interaction rather than enzymatic catalysis.
• Therapeutic Potential: Since AdvA is essential for A. baumannii division and is absent in humans, it represents a promising target for new antimicrobials. The unique structural features (the $\alpha$6 helix and the positively charged tip) provide specific targets for drug design that would not affect human proteins or other bacteria relying on FtsEX.
• Antibiotic Resistance: The link between the AdvA C-terminal domain and fluoroquinolone resistance suggests that disrupting this protein could re-sensitize MDR strains to existing antibiotics.

In summary, this study elucidates how A. baumannii has evolved a unique, non-enzymatic, cyclase-fold protein (AdvA) to orchestrate cell division in the absence of conserved regulatory machinery, offering a new avenue for combating this urgent public health threat.